Loading clinical trials...
Loading clinical trials...
Phase II Clinical Trial of AZD2171 Monotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Patients
Conditions
Interventions
Cediranib Maleate
Laboratory Biomarker Analysis
Locations
1
United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Start Date
February 1, 2007
Primary Completion Date
May 1, 2013
Completion Date
July 1, 2014
Last Updated
May 5, 2015
NCT06980038
NCT06868433
NCT06636734
NCT04754321
NCT05063552
NCT04588038
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions